Publication | Open Access
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma
57
Citations
25
References
2015
Year
Drug TargetingHuman NeuroblastomaTumor VascularMedicineTherapeutic ActivityTumor TargetingAnti-cancer AgentCancer TreatmentPharmacologyCell BiologyCancer Research
Page 1
Page 1